Publications
Primary standardization of 224RA activity by liquid scintillation counting. Elisa Napoli, Jeffrey T. Cessna, Ryan Fitzgerald, Leticia Pibida, Ronald Collé, Lizbeth Laureano-Pérez, Brian E. Zimmerman, Denis E.Bergeron; Applied Radiation and Isotopes Volume 155, January 2020, 108933 (external link)
Ra-224 labeling of calcium carbonate microparticles for internal α-therapy: Preparation, stability, and biodistribution in mice. Westrøm S, Malenge M, Jorstad IS, Napoli E, Bruland Ø, Bønsdorff TB, Larsen R; J Labelled Comp Radiopharm. 2018 May 30;61(6):472-486.
Evaluation of CD146 as Target for Radioimmunotherapy against Osteosarcoma. Westrøm S, Bønsdorff TB, Abbas N, Bruland ØS, Jonasdottir TJ, Mælandsmo GM, Larsen RH. PLoS One. 2016 Oct 24;11(10)
Therapeutic Effect of α-Emitting 224Ra-Labeled Calcium Carbonate Microparticles in Mice with Intraperitoneal Ovarian Cancer. Westrøm S, Bønsdorff TB, Bruland ØS, Larsen RH. Translational Oncology. 2018 Jan 27;11:259-267
Preparation of 212Pb-labeled monoclonal antibody using a novel 224Ra-based generator solution. Westrøm S, Generalov R, Bønsdorff TB, Larsen RH. Nuclear Medicine and Biology. 2017 Apr 26;51:1-9
Release and retention of 212Pb from 224Ra-labeled microparticles. Napoli E, Westrøm S, Bønsdorff TB, Bruland Ø, Larsen R.; The Society of Nuclear Medicine and Molecular Imaging (SNMMI) 2018 Annual Meeting in Philadelphia, USA
Posters
A primary activity standard for the alpha-emitting radionuclide Ra-224 (SNMMI 2019)
A primary activity standard for the alpha-emitting radionuclide Ra-224 (SNMMI 2019)
Biodistribution of RA-224 and its progeny PB-212 after intraperitoneal infusion of RA-224 labeled microparticles in rats (AACR 2019)
Alpha-Emitting Radiopharmaceutical for IP Therapy of Peritoneal Metastases (EANM2018)
Alpha-Emitting Radiopharmaceutical for IP Therapy of Peritoneal Metastases (EANM2018)
Preclinical Evaluation of a Novel Alpha-Particle (ESGO7-0822)
Preclinical Evaluation of a Novel Alpha-Particle (ESGO7-0822)